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Abstract
Objectives: The aim of the present study was to compare a newly developed biodegradable
polylactide/polyglycolide/N-methyl-2-pyrrolidone (PLGA/NMP) membrane with a standard resorbable
collagen membrane (RCM) in combination with and without the use of a bone substitute material
(deproteinized bovine bone mineral [DBBM]) looking at the proposed tenting effect and bone
regeneration.
Materials and methods: In five adult German sheepdogs, the mandibular premolars P2, P3, P4, and
the molar M1 were bilaterally extracted creating two bony defects on each site. A total of 20 dental
implants were inserted and allocated to four different treatment modalities within each dog: PLGA/
NMP membrane only (Test 1), PLGA/NMP membrane with DBBM (Test 2), RCM only (negative control),
and RCM with DBBM (positive control). A histomorphometric analysis was performed 12 weeks after
implantation. For statistical analysis, a Friedman test and subsequently a Wilcoxon signed ranks test
were applied.
Results: In four out of five PLGA/NMP membrane-treated defects, the membranes had broken into
pieces without the support of DBBM. This led to a worse outcome than in the RCM group. In
combination with DBBM, both membranes revealed similar amounts of area of bone regeneration and
bone-to-implant contact without significant differences. On the level of the third implant thread, the
PLGA/NMP membrane induced more horizontal bone formation beyond the graft than the RCM.
Conclusion: The newly developed PLGA/NMP membrane performs equally well as the RCM when
applied in combination with DBBM. Without bone substitute material, the PLGA/NMP membrane
performed worse than the RCM in challenging defects, and therefore, a combination with a bone
substitute material is recommended.
In the field of guided bone regeneration (GBR),
there has been a dramatic reduction in the use of
non-resorbable membrane like the expanded
polytetrafluoroethylene (ePTFE), due to difficul-
ties in handling, the need for a second surgery to
remove the membrane, and the low reproduci-
bility of results when membrane exposure had
occurred resulting in wound infection and subse-
quently poor bone regeneration (Gher et al. 1994;
Simion et al. 1994; Machtei 2001). To overcome
these shortcomings, non-resorbable membranes
were replaced in many indications by resorbable
collagen membranes (RCMs) made from bovine
or porcine sources (Parodi et al. 1998; Hammerle
& Lang 2001). With improved biocompatibility,
biodegradability, and better treatment results,
most clinicians nowadays use RCMs (Lang
et al. 2007; Hammerle et al. 2008). All collagen
membranes originate from animal sources,
which can cause difficulties for patient accep-
tance, immune responses, and a transmission of
infectious agents can never be completely ex-
cluded. Few studies have reported that these
membranes do exhibit unfavourable mechanical
properties (Hurzeler et al. 1998) and inadequate
barrier stability over time (Miller et al. 1996;
Zhao et al. 2000; Owens & Yukna 2001).
The usage of synthetic resorbable membranes
made from aliphatic polyesters like polylactide,
polyglycolide, and trimethylcarbonate has also
been reported (Rosen & Reynolds 2001; Kohal
& Hurzeler 2002). However, the degradation
process of synthetic membranes made of polylac-
tide or polyglycolide acids can impair bone re-
generation due to adverse inflammatory tissue
reaction (von Arx et al. 2002, 2005). Therefore,
the development of a membrane based on bio-
compatible synthetic material with a long record
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of accomplishment in human use would repre-
sent an important step forward in GBR and in
implantology. In this trial, a biodegradable fully
synthetic membrane composed of polylactide,
polyglycolide (PLGA), and trimethylene carbo-
nate membrane was used as a barrier membrane
for GBR in the dog mandible. The PLGA-based
membrane is degradable by hydrolysis and re-
leases N-methyl-2-pyrrolidone (NMP), which
was shown to accelerate the maturation of pre-
osteoblastic cells and bone regeneration in vitro
and in vivo in a cranial defect model in rabbits
(Miguel et al. 2009). Hence, it might be expected
that this PLGA/NMP membrane is capable of
enhancing bone regeneration in a GBR model in
humans as well. Unlike collagen-based mem-
branes, PLGA-based membranes are stiff and
can only be used clinically for GBR when sof-
tened by a plasticizer, such as NMP. Because
NMP is released from the membrane when in
contact with body fluids (Pirhonen et al. 2006),
the appliedmembrane becomes stiff again, which
might allow to omit the use of membrane-sup-
porting materials. Owing to the low mechanical
stability, collagen-derivedmembranes aremainly
applied in combination with bone substitute
materials (Jung et al. 2003; Cornelini et al. 2004).
The aim of this study was to compare the
PLGA/NMP membrane with a standard RCM
with and without the addition of deproteinized
bovine bone mineral (DBBM) as bone substitute










from Geistlich AG (Wolhusen, Switzerland).
The synthetic Inion
s
GTRt membrane and the
resorbable pins were purchased from Inion Oy
(Tampere, Finland). The Straumann Dental Im-
plant System was purchased from Straumann
AG (Basel, Switzerland). Both membranes were
applied as recommended by the manufacturer.
The following procedures was used for the novel
PLGA/NMP membrane: After unwrapping, the
stiff PLGA membrane was located in a tray. To
soften the PLGA membrane, the supplied NMP
solution was added to the tray and allowed to
penetrate the membrane for 30 s. After soaking,
the membrane was taken from the tray with
tweezers and placed for 10min in the second
part of the tray to allow an even distribution of
NMP throughout the membrane and an air dry-
ing of its surface. Then, the originally stiff mem-
brane had turned into a soft membrane, which
can be applied clinically.
Animals
Five adult German sheepdogs, weighing more
than 20kg, were used in the present study. The
animals were kept in a purpose-designed room for
experimental animals and were fed with a stan-
dard laboratory diet. The study was evaluated and
accepted by the responsible Veterinary Authority
(University of Belgrade, Serbia). All surgical pro-
cedures including extraction and implant place-
ment were performed under general anaesthesia
according to an earlier study (Jung et al. 2007).
Surgical procedure
Oral prophylaxis comprising of calculus removal
and chlorhexidine swabs was performed 1 week
before tooth extraction and 1 week before the
regenerative surgery using drug sedation.
Surgery 1 (tooth extraction)
From five dogs, the mandibular premolars P2,
P3, P4, and the molar M1 were extracted bilat-
erally. Wound closure was achieved using resorb-
able sutures.
Surgery 2 (implantation and lateral ridge
augmentation)
Implantation and regenerative surgery was per-
formed 3 months following tooth extraction.
Following mid-crestal incisions of 2.5 cm in
length as well as buccal vertical releasing inci-
sions distal to the canine, a full-thickness flap
was carefully elevated. On each side of the
mandible, two angular ridge form defects with
the following dimensions were created: 9mm in
the mesio-distal direction, 5mm in the apical–
coronal direction, and 7mm in the bucco-oral
direction. A total of 20 experimental implants
with a sandblasted, large-grit, acid-etched surface
up to the shoulder of the Straumann Dental
Implant System (Straumann AG) with a dia-
meter of 3.3mm and a length of 8mm were
placed obtaining primary stability (Fig. 1a and b).
One implant was placed per defect in such a
way that the implant-shoulder was vertically
located at the level of the alveolar bone crest at
the lingual side. This resulted in a buccal dehis-
cence defect (Fig. 1b). At this time point, the
vertical defect extension was measured from the
top of the implant cylinder shoulder to the first
bone-to-implant contact at the buccal aspect.
The four implants inserted in each of the five
dogs were randomly allocated to the PLGA/NMP
group or RCM group either in combination with
DBBM or without resulting in the following four
treatment modalities:
Test 1 – PLGA/NMP membrane only: biodegrad-
able polylactide, polyglycolide, trimethylene carbo-
nate-based and N-methylpyrrolidone (NMP)-
releasing membrane (PLGA/NMP) membrane
(Inion
s
GTRt) without bone substitute material.
Test 2 – PLGA/NMP membrane with DBBM:
biodegradable PLGA/NMP membrane (Inion
s
GTRt) with DBBM (Bio-Oss
s
) as bone substitute
material.
Positive control – RCM with DBBM: RCM
(Bio-Gide
s




Negative control – RCM only: RCM (Bio-
Gide
s
) without bone substitute material.
For the Test 2 and positive control modalities,
the DBBM granules were mixed with a sterile
saline solution and placed into the bone defects.
Before applying the membrane, the horizontal
defect extensions were measured from the buccal
implant surface to the most buccal aspect of the
graft material. Both types of membranes were
trimmed and draped over the defect and the
adjacent ridge in order to overlap the defect
margins 2–3mm. Each membrane was secured
at the buccal aspect with two resorbable tri-
methylene carbonate/D, L-lactide tacks (Inion
Oy) and tucked underneath the lingual flap
(Fig. 2a and b). At the test sites, the bioresorbable
PLGA/NMP membranes were moistened with
sterile saline solution and subsequently the
membrane became stiff after approximately 90 s.
To allow a tension-free wound closure, the
periosteum of the buccal flap was relieved along
the entire base. Thereafter, primary wound clo-
sure was obtained with a vertical mattress and
interrupted e-PTFE sutures (Gore-Tex
s
sutures
5.0, W. L. Gore & Assoc., Flagstaff, AZ, USA).




Fig. 1. (a and b) Clinical photographs of bony defects beforemembrane and bone substitute application. The dimensions of the
defects were 9 mm in the mesio-distal direction and 5 mm in the apical–coronal direction.
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larly injected to reduce postoperative pain. The
dogs remained on a soft diet for the remainder of
the study. The dogs were kept in a purpose-
designed cage and allowed once a day 2h into
an outdoor environment. The sutures were re-
moved 10 days after surgery.
Three months following regenerative surgery,
animals were sacrificed with an overdose of
intravenous sodium pentobarbital under deep
anaesthesia. All sites were harvested with intact
soft tissues.
Histological preparation
Fixation of the block sections was performed in
4% formaldehyde for 2 weeks. Following fixa-
tion, the specimens were rinsed in running tap
water, trimmed and dehydrated in a graded series
of increasing ethanol concentrations. Embedding
was performed in methylmethacrylate. Tissue
blocks were cut into 200-mm-thick vertical sec-
tions using a diamond saw (Exakt, Norderstedt,
Germany). The sections were ground and po-
lished to a final thickness of 40–80mm (Exakt),
and surface-stained with toluidine blue (Schenk
et al. 1984).
Histomorphometry
From each specimen, the central orofacial section
through the implant was selected for a quantita-
tive assessment of different linear measurements
(vertical and horizontal extension of the regener-
ated bone), interfaces, and various tissue compo-
nents by applying standard morphometrical
techniques (Weibel et al. 1966; Gundersen et al.
1988). Measurements were performed directly
under a light microscope (Leica Microsystems
AG, Heerbrugg, Switzerland).
Linear measurements were performed at a
magnification of 40 times in order to calculate
the amount of regenerated bone in the former
defect area:
(a) The area of regenerated bone was calculated
as the area of newly formed bone in mm2
within the area outlined by the membrane.
(b) Bone-to-implant contact was evaluated from
the base of the prepared defect to the implant
shoulder and was calculated in mm.
(c) The vertical extension of the regenerated bone
wasmeasured from the implant shoulder to (i)
the highest bone-to-implant contact and (ii) to
the highest extension of newly formed bone at
the buccal side of the implant. The implant
shoulder was set as zero and negative values
represent bone tissue below the implant
shoulder, whereas positive values reveal
bone tissue above the implant shoulder.
(d) To obtain quantitative information about
the horizontal extension of regenerated
bone, the distance from the outer surface of
the regenerated bone to the implant surface
was measured perpendicular to the implant
at the level of the first three threads.
(e) To obtain quantitative information about
the horizontal extension of regenerated
bone beyond the augmented area, the dis-
tance from the outer surface of the regener-
ated bone to the outer surface of the graft
material was measured perpendicular to the
implant at the level of the first three threads.
Negative values represent graft material ex-
ceeding bone tissue horizontally, whereas
positive values reveal bone tissue formation
beyond the graft material.
Statistical analysis
All data for statistical variables of new bone
formation, membrane material, and non-miner-
alized tissue were first analysed by a Friedman
test and if applicable by a Wilcoxon signed ranks
test using the SSPS software version 18.0 (SPSS
Inc., Chicago, IL, USA). The animal was chosen
as the unit for statistical analysis. The level of
significance chosen in all statistical tests was set
at Po0.05.
Results
All surgical procedures went uneventful with the
exception of one dog, where residual tooth pieces
were found. Because the removal of these pieces
led to a very huge defect, no implant could be
placed at one of the four defect sites. This situa-
tion led to the exclusion of this site from further
analysis. Before and after the surgical procedures,
all dogs stayed in good health. Soft tissue healing
was excellent at all sites and no dehiscence was
detected. Histological analysis (Fig. 3d) revealed
Fig. 2. (a) Clinical photographs of deproteinized bovine bonemineral placed in the bony defects and (b) covered with polylactide/
polyglycolide/N-methyl-2-pyrrolidone membrane held in place by resorbable trimethylene carbonate/D, L-lactide tacks.
Fig. 3. Histological views of all treatment modalities in a single dog. (a) Resorbable collagen membrane (RCM) with
deproteinized bovine bone mineral (DBBM) showing good bone regeneration and (c) without bone substitute material. (b) The
polylactide/polyglycolide/N-methyl-2-pyrrolidone (PLGA/NMP) membrane group with bone substitute material (DBBM)
shows good bone regeneration even with broken membrane fragments and (d) PLGA/NMP membrane group without bone
substitute material showing the remnants of the broken PLGA/NMP membrane.
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that in four out of five PLGA/NMP membrane-
treated defects the membranes had broken into
pieces. In the PLGA/NMP membrane/DBBM
group, only one membrane had broken (Fig. 3b).
Therefore, the tenting effect of the PLGA/NMP
membrane is apparently not sufficient to main-
tain the space in extended defects in dogs. How-
ever, when supported by bone substitutematerial
(DBBM), the stability increased substantially. In
terms of bone formation, the fracture of the one
PLGA/NMP membrane in the PLGA/NMP
membrane/DBBM group had no negative impact
on bone formation. In contrast to the PLGA/
NMP membrane, all RCMs remained intact at
all sites and presumably, maintained their barrier
function (Fig. 3a and c).
The histomorphometric data are displayed in
Table 1. As shown in Fig. 4a, the area of regen-
erated bone was identical for both membranes in
the DBBM group and in the group without
DBBM. In addition, the influence of the mem-
brane on the bone/implant interphase was eval-
uated. As shown in Fig. 4b, the two membranes
had no significant influence on the bone-to-im-
plant contact. But without bone substitute ma-
terial, the overall bone-to-implant contact was
higher in the RCM group compared with the
PLGA/NMP group. The difference between the
PLGA/NMP group with DBBM and without
DBBM was significant.
The success of an implant depends on its
osseous integration. Therefore, the highest point
of bone-to-implant contact and the highest bone
tissue level were determined (Fig. 5a and b). The
results showed that between the corresponding
groups (with and without DBBM) no significant
difference could be detected. The difference be-
tween the highest bone tissue level of the PLGA/
NMP group with DBBM compared with both
membranes without DBBM (N¼5, P¼0.034)
was significant.
Horizontal bone gain was assessed at three
different levels (first, second, and third thread).
The results revealed no significant difference in
horizontal bone formation between the two
membranes at any level (Fig. 6a). In addition,
we determined bone regeneration beyond the
graft material. When compared with RCMs, the
PLGA/NMP membrane was capable of inducing
bone regeneration horizontally beyond the graft
material in the lower region of the defect (Fig.
6b). At the level of the third thread, there was a
bigger difference between the two membranes,
however, reaching no statistically significant
difference.
Discussion
The present dog study demonstrates that a newly
developed PLGA/NMP membrane in combina-
tion with a membrane supporting material
(DBBM) revealed no significant differences in
the majority of the tested parameters compared
with the use of an RCM with DBBM. The only
small difference of the PLGA/NMP membrane
was that on the level of the third thread of the
implant, more bone had formed horizontally
beyond the graft material in the PLGA/NMP
group comparedwith the RCM group. This small
edge might derive from the use of NMP, known
to enhance autologous and recombinant bone
morphogenetic proteins yielding into enhanced
bone regeneration (Miguel et al. 2009).





RCM (N¼ 5) PLGA/NMP (N¼ 5)
Area of bone regeneration (mm2) 9.53  .3.46 10.03  5.76 2.53  2.69 1.27  1.82
Po0.032
Bone-to-implant contact (mm) 3.05  1.46 2.56  1.06 1.72  1.4 0.46  4.88
Po0.043
Implant shoulder highest bone implant contact (mm)  1.29  0.41  1.39  0.81  2.62  1.63 2.73  1.14
Po0.043
Implant shoulder highest bone (mm) 0.63  0.91 1.03  0.61  2.53  1.65 2.63  1.24
RCM, resorbable collagen membrane; DBBM, deproteinized bovine bone mineral; PLGA/NMP, polylactide/polyglycolide/N-methyl-2-pyrrolidone.
Fig. 4. Analysis of histomorphometry. (a) Area of bone regeneration and (b) bone-to-implant contact. The lines to the right of
the values indicate the median of the group. Significant difference between groups is indicated with (n).
Fig. 5. (a) Distance between implant shoulder and the highest bone-to-implant contact and (b) distance between implant
shoulder and the highest extent of bone tissue. The lines to the right of the values indicate themedian of the group. Significant
differences between groups are indicated with (n).
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The newly developed PLGA/NMP membrane
is initially composed of a stiff material (polygly-
colide, polylactide). For medical use, thematerial
has to be softened, which is facilitated by incuba-
tion in and influx of NMP. Upon placement in
the patient and the resulting exposure to body
fluids, the softener NMP is released, increasing
the stiffness of the membrane again (Pirhonen et
al. 2006). The outcome of the present experiment
revealed that the regained stiffness is not suffi-
cient to maintain a space for bone ingrowth by its
own, because in four of five cases the PLGA/
NMP membrane broke. Therefore, the tenting
effect of this membrane on its own is limited. A
reason for this outcome might be that the design
of the study aimed toward a challenging defect
size, which would not be treated without bone
substitute material in a human situation. Be-
cause the forces applied on the membranes by
the dogs could not be controlled beyond the
feeding of soft meals, it remains unclear whether
a PLGA/NMP membrane can withstand the
‘‘normal’’ forces in humans. In a recent human
trial, the same membrane was used to cover
extraction sockets of impacted wisdom teeth
(Zwahlen et al. 2009). Histological data and
clinical outcome provided no indications for
membrane fractures and/or failures. However,
one has to take into account that in this human
trial the blood clot underneath themembrane had
been stabilized by a collagen sponge and that the
defects created were four-wall instead of three-
wall bony defects as in the present dog model.
It is worth mentioning that the failure of the
PLGA/NMP membrane led to a worse outcome
than the collapsing collagenmembrane. Thismight
have two reasons: First, the collagenmembrane did
not rupture and maintained its barrier function.
Therefore, soft tissue in-growth was still prevented
in the RCM group, whereas the broken PLGA/
NMP membrane allowed fibrous tissue in-growth
into the regenerating area (Fig. 3d). Second, the
pieces of the broken PLGA/NMP membrane
stacked onto the defect and hindered new bone
formation physically, leading to a significant reduc-
tion of the bone-to-implant contact (Fig. 4b). When
the PLGA/NMP membrane was applied without
DBBM compared with its application with DBBM,
no significant difference was found between both
membranes either applied with or without DBBM.
An earlier study in mongrel dogs (Kohal et al.
1999) evaluated the effect of GBR without the
application of a bone substitute material around
non-submerged implants using different barrier
membranes in three groups: (a) an ePTFE mem-
brane, (b) a bioresorbable membrane made from a
synthetic copolymer of glycolide and lactide, and
(c) no membrane application. The defects (5mm
apicocoronal  5mm mesiodistal) were not
filled with a bone substitute material. After a
healing period of 6 months, the mineralized
bone-to-implant contact in the bioinert e-PTFE
membrane group was 51.5%, in the control
group 46.3%, and 37.5% in the biodegradable
membrane group. The results of this study in-
dicated that GBR with a bioinert e-PTFE mem-
brane was equal without using bone substitute
material. However, compared with the present
study, the defect size was much smaller and less
challenging, because all four bony walls were
preserved.
In combination with the bone substitute ma-
terial DBBM, RCMs and PLGA/NMP mem-
branes performed equally well in terms of area
of bone regeneration, bone-to-implant contact,
horizontal bone gain, and all the other parameters
tested. One difference was seen in the horizontal
extension of bone tissue compared with
graft material at the level of the third thread
(Fig. 6b). This result might be explained by the
fact that NMP released from the membrane
increases bone formation more at the bottom of
a defect and closer to the membrane. The first
vector (closer to the bottom) is most likely due to
the higher density of NMP compared with body
fluid. The second (closer to the membrane) can
be due to the constant release of residual NMP
from the membrane. Both not only support the
concept of the bioactivity of NMP (Miguel et al.
2009) but also highlight the difficulty in applying
it in traditional applications of membranes in
humans, because most of the NMP will flow
out of the defect site. This in vivomodel was able
to document the bioactivity of NMP in a calvarial
defect model where PLGA/NMP membranes
were placed at both sides of the defect. This
defect anatomy allowed to trap the released
NMP within the bony borders of the bone defect
(Miguel et al. 2009). This configuration, in con-
trast to normal dental applications, might have
increased the effective concentration of NMP in
the defect and prolonged its exposure to the
resident cells close to the defect margins with
regenerative potential.
A similar situation in humans concerning the
bony walls exists in extraction sockets. Hence,
the first clinical trial to evaluate the osteopromo-
tive effect of NMP within the PLGA/NMP
membrane was performed in an extraction socket
model. The results of that clinical trial with the
Fig. 6. (a) Horizontal bone gain measured perpendicular to the implant at the level of thread 1, 2, and 3. (b) Horizontal bone
gain beyond the graft material determined by the distance from the outer surface of the regenerated bone to the outer surface of
the graft material measured perpendicular to the implant at the level of thread 1, 2, and 3. Positive values indicate that bone
had formed horizontally beyond the graft material at the buccal side. No significant differences were observed between the
corresponding groups.
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PLGA/NMP membrane showed that old bone
density around the defect had increased in the
PLGA/NMP group compared with the RCM
group (Zwahlen et al. 2009); however, the num-
ber of patients and the magnitude of this effect
were too low to show a highly significant in-
crease in bone formation or bone density between
the groups.
The present study design did not include an
empty control in order to assess the amount of
spontaneous healing within this type of defects.
This would allow to better interpret the outcome
of bone regeneration; however, on the other hand,
the tenting effect of the different membranes
could not been assessed.
In conclusion, the newly developed fully syn-
thetic biodegradable PLGA/NMP membrane per-
forms equally as well as the resorbable collagen-
based membrane when applied in combination
with a bone substitute material. A small increase
in the horizontal bone gain beyond the graft
material at the level of the third thread of the
implant might be attributed to the osteopromo-
tive action of NMP. Without bone substitute
material, the PLGA/NMP membrane performed
worse than the resorbable collagen-based mem-
brane in challenging defects. Therefore, the com-
bination with a bone substitutematerial is highly
recommended.
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